Pfizer epilepsy drug Lyrica fails in phase III trial Medical Dialogues Bureau28 May 2019 3:30 AM GMTNew Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...